Sign inGet started

Ashe Carol Gail

Insider CIK 1761748 · ELTX Director · APTO Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ELTX Elicio Therapeutics, Inc. A Award deriv2026-08-312026-09-0221,750— $021,750SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2026-08-312026-09-0221,750— $021,750SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2025-05-192025-05-207,900— $07,900SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2024-11-212024-11-254,100— $04,100SEC↗
APTO Aptose Biosciences Inc. A Award deriv2024-02-052024-02-073,333— $03,333SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2023-12-282023-12-294,100— $04,100SEC↗
APTO Aptose Biosciences Inc. A Award deriv2023-01-192023-01-23100,000— $0100,000SEC↗
APTO Aptose Biosciences Inc. A Award deriv2022-01-182022-01-2050,000— $050,000SEC↗
APTO Aptose Biosciences Inc. A Award deriv2021-01-042021-01-0650,000— $050,000SEC↗
APTO Aptose Biosciences Inc. A Award deriv2020-03-112020-03-1350,000— $050,000SEC↗
APTO Aptose Biosciences Inc. A Award deriv2020-01-312020-02-0365,000— $065,000SEC↗
APTO Aptose Biosciences Inc. A Award deriv2019-01-022019-01-0340,000— $040,000SEC↗